Table 2 Lead SNPs in top loci associated with PTSD cases in the discovery cohort (CCSS) and their results in the replication cohort (SJLIFE) and in meta-analysisa.
Model 1b | Model 2c | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Chr | Position | SNP | Gene | A1 | A2 | Sample | RAF | OR (95% CI) | P | OR (95% CI) | P |
10 | 135208461 | rs34713356 | MTG1 | A | G | CCSS | 0.14 | 1.57 (1.35–1.84) | 1.36 × 10–8 | 1.61 (1.37–1.90) | 6.41 × 10–9 |
SJLIFE | 0.15 | 1.37 (1.00–1.87) | 0.047 | 1.39 (0.99–1.95) | 0.058 | ||||||
Meta-analysis | - | 1.53 (1.34–1.75) | 8.55 × 10–10 | 1.57 (1.36–1.82) | 1.38 × 10–9 | ||||||
6 | 148472854 | rs9390543 | SASH1 | G | A | CCSS | 0.45 | 0.75 (0.67–0.85) | 3.56 × 10–6 | 0.74 (0.65–0.84) | 1.86 × 10–6 |
SJLIFE | 0.43 | 0.74 (0.58–0.93) | 0.011 | 0.74 (0.58–0.96) | 0.02 | ||||||
Meta-analysis | - | 0.75 (0.68–0.83) | 2.02 × 10–8 | 0.74 (0.66–0.83) | 1.18 × 10–7 | ||||||